We are live on ! Find out more
EFM

E Fund Management Portfolio holdings

AUM $3.37B
This Fund
S&P 500
This Quarter Est. Return
+11.07%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.1B
AUM Growth
-$1.95B
Cap. Flow
-$2.01B
Cap. Flow %
-182.11%
Top 10 Hldgs %
55.43%
Holding
359
New
34
Increased
188
Reduced
93
Closed
36

Top Buys

Rank Stock Value
1
STAA icon
STAAR Surgical
STAA
+$38.7M
2
SE icon
Sea Limited
SE
+$29.1M
3
MELI icon
Mercado Libre
MELI
+$27M
4
META icon
Meta Platforms (Facebook)
META
+$19.3M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$17.2M

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$1.32B
2
JD icon
JD.com
JD
+$301M
3
BIDU icon
Baidu
BIDU
+$279M
4
NTES icon
NetEase
NTES
+$202M
5
TCOM icon
Trip.com Group
TCOM
+$77.3M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 35.58%
2 Technology 17.59%
3 Communication Services 16.9%
4 Healthcare 11.23%
5 Real Estate 6.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BMY icon
176
Bristol-Myers Squibb
BMY
$127B
$427K 0.04%
5,545
-346
-6% -$26.4K
DHR icon
177
Danaher
DHR
$135B
$425K 0.04%
1,893
+31
+2% +$7.14K
ILMN icon
178
Illumina
ILMN
$29.4B
$423K 0.04%
2,359
+176
+8% +$44.9K
VZ icon
179
Verizon
VZ
$194B
$423K 0.04%
8,339
+263
+3% +$13.3K
EXAS
180
DELISTED
Exact Sciences
EXAS
$418K 0.04%
10,620
+6,345
+148% +$339K
ANSS
181
DELISTED
Ansys
ANSS
$417K 0.04%
1,744
-12
-0.7% -$3.17K
CRSP icon
182
CRISPR Therapeutics
CRSP
$4.58B
$417K 0.04%
+6,868
New +$404K
CDNA icon
183
CareDx
CDNA
$1.92B
$414K 0.04%
19,289
+10,574
+121% +$293K
INSM icon
184
Insmed
INSM
$23.2B
$414K 0.04%
21,006
+8,890
+73% +$186K
HZNP
185
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$409K 0.04%
5,126
+2,463
+92% +$233K
APH icon
186
Amphenol
APH
$188B
$405K 0.04%
12,580
-120
-0.9% -$4.17K
DLTR icon
187
Dollar Tree
DLTR
$23.1B
$404K 0.04%
2,591
+26
+1% +$4.12K
ZNTL icon
188
Zentalis Pharmaceuticals
ZNTL
$308M
$403K 0.04%
14,356
+8,277
+136% +$219K
JD icon
189
JD.com
JD
$40.8B
$402K 0.04%
6,264
-5,209,303
-100% -$301M
SRNE
190
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$395K 0.04%
196,273
+73,225
+60% +$127K
EA icon
191
Electronic Arts
EA
$52.4B
$393K 0.04%
3,231
-48
-1% -$6.12K
PMVP icon
192
PMV Pharmaceuticals
PMVP
$66.1M
$392K 0.04%
+27,501
New +$400K
ASML icon
193
ASML
ASML
$675B
$389K 0.04%
818
+30
+4% +$16.7K
ISEE
194
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$387K 0.04%
40,201
+23,831
+146% +$299K
IMGN
195
DELISTED
Immunogen Inc
IMGN
$386K 0.04%
85,764
+42,978
+100% +$187K
TEL icon
196
TE Connectivity
TEL
$58.8B
$384K 0.03%
3,391
-74
-2% -$9.17K
CLDX icon
197
Celldex Therapeutics
CLDX
$2.77B
$383K 0.03%
14,200
+6,362
+81% +$185K
DVAX
198
DELISTED
Dynavax Technologies
DVAX
$382K 0.03%
30,319
+2,806
+10% +$29.8K
MSI icon
199
Motorola Solutions
MSI
$69.4B
$369K 0.03%
1,760
-37
-2% -$8.07K
WBA
200
DELISTED
Walgreens Boots Alliance
WBA
$367K 0.03%
9,671
+149
+2% +$6.41K
6 7
8
9 10

Similar funds

VFCM
Valley Forge Capital Management Miami, Florida $3.38B AUM 15.93% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
DIA
Dana Investment Advisors Waukesha, Wisconsin $3.35B AUM 29.65% 1-Year Est. Return
5NCM
59 North Capital Management Houston, Texas $3.35B AUM 22.14% 1-Year Est. Return
TAM
Troy Asset Management London, United Kingdom $3.35B AUM 11.7% 1-Year Est. Return
CS
CapitalatWork SA Auderghem $3.35B AUM
OAM
Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return
QCG
Quadrant Capital Group Cincinnati, Ohio $3.34B AUM 29.16% 1-Year Est. Return

E Fund Management's Q2 2022 Portfolio in Review

As of Q2 2022, E Fund Management held 359 positions worth $1.1B, down 64% from $3.06B the previous quarter. Its ten largest holdings account for 55% of the portfolio.

E Fund Management withdrew a net $2.01B in Q2 2022, closing 36 positions and reducing 93 holdings. Its most notable exit was Alibaba, an estimated $1.32B position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 36% of assets, down from 63% a quarter earlier, followed by Technology and Communication Services.

Against the trend, E Fund Management opened a new position in Sea Limited worth $22.9M.

  • E Fund Management's largest Q2 2022 buy was Sea Limited: 342,000 shares worth $22.9M.
  • E Fund Management added most to STAAR Surgical in Q2 2022, an estimated $38.7M increase.
  • E Fund Management's biggest Q2 2022 reduction was JD.com, cutting an estimated $301M.
  • E Fund Management fully exited Alibaba in Q2 2022, selling an estimated $1.32B.
  • E Fund Management's ten largest holdings make up 55% of its $1.1B portfolio in Q2 2022.
  • E Fund Management opened 34 new positions and closed 36 in Q2 2022.
  • E Fund Management's portfolio value fell 64% quarter-over-quarter to $1.1B.

Based on E Fund Management's 13F filing for Q2 2022, filed 15 Aug 2022.